Medicaid Monitor
Policy Intelligence
Medicaid Monitor
Policy Intelligence
© 2026 Lanphier Ventures, LLC
Informational use only. Not legal or compliance advice.
← All stories
Federal Policy·June 8, 2026

HHS Autism Panel Endorses Unproven Communication Methods and Alternative Treatments

Health Secretary Robert F. Kennedy Jr.'s newly formed autism panel is promoting controversial and scientifically unvalidated treatments and communication methods for autism, including facilitated communication techniques, stem cell injections, and alternative therapies like camel's milk. The panel's endorsement of these approaches, which lack evidence-based support and have been criticized by medical professionals, represents a departure from established clinical guidance. This development affects Medicaid managed care organizations responsible for autism services coverage and prior authorization decisions. Critics warn the promoted methods risk harm and exploitation of vulnerable populations.

Why it matters for managed care

Medicaid MCOs may face pressure to cover unproven autism treatments endorsed by federal leadership, creating coverage determination and utilization management challenges while exposing plans to quality and medical necessity disputes.

Behavioral Health

Read the full article at kffhealthnews.org

Share this briefing

You might also like

← All stories

Get the daily briefing.